Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

Hormonal imbalances are important in the development of male pattern baldness.

The conclusion is that hirsutism is strongly linked to PCOS and higher levels of certain hormones, but not to DHEAS, prolactin, cortisol, or TSH.

More men have androgenic alopecia than women, with stress linked to the condition in both genders.

The conclusion is that more women in their forties are getting AGA and stress is linked to AGA in both men and women.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

Topical finasteride is promising for hair loss with minimal side effects but needs more research and approval.

Healthy scalp is crucial for hair growth and preventing hair loss.

Kidney stones and hair loss are significantly related in people under 60 years old.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Woman with diabetes had hair loss due to rare ovarian tumor; surgery improved hair growth.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

A subtle androgen receptor abnormality can allow normal male development and sometimes fertility despite partial androgen resistance.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Different hair loss patterns may be linked to varying male hormone levels.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.